These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 9768712)

  • 1. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction.
    Afridi I; Grayburn PA; Panza JA; Oh JK; Zoghbi WA; Marwick TH
    J Am Coll Cardiol; 1998 Oct; 32(4):921-6. PubMed ID: 9768712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. Investigators of this Multicenter Study.
    Meluzín J; Cerný J; Frélich M; Stetka F; Spinarová L; Popelová J; Stípal R
    J Am Coll Cardiol; 1998 Oct; 32(4):912-20. PubMed ID: 9768711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of patients with chronic coronary artery disease and severe left ventricular dysfunction. The importance of myocardial viability.
    Meluzín J; Cerný J; Spinarová L; Toman J; Groch L; Stetka F; Frélich M; Hude P; Krejcí J; Rambousková L; Panovský R
    Eur J Heart Fail; 2003 Jan; 5(1):85-93. PubMed ID: 12559220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure.
    Senior R; Kaul S; Lahiri A
    J Am Coll Cardiol; 1999 Jun; 33(7):1848-54. PubMed ID: 10362184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis.
    Allman KC; Shaw LJ; Hachamovitch R; Udelson JE
    J Am Coll Cardiol; 2002 Apr; 39(7):1151-8. PubMed ID: 11923039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose dobutamine echocardiography predicts recovery of left ventricular systolic function following revascularization even in presence of low contractile reserve.
    Kasliwal RR; Paul B; Mustaqueem A; Bansal M; Trehan N
    Indian Heart J; 2006; 58(2):120-5. PubMed ID: 18989055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative selection of patients with severely impaired left ventricular function for coronary revascularization. Role of low-dose dobutamine echocardiography and exercise-redistribution-reinjection thallium SPECT.
    Vanoverschelde JL; Gerber BL; D'Hondt AM; De Kock M; Dion R; Wijns W; Melin JA
    Circulation; 1995 Nov; 92(9 Suppl):II37-44. PubMed ID: 7586440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of global left ventricular function after bypass surgery in patients with severe left ventricular dysfunction. Impact of pre-operative myocardial function, perfusion, and metabolism.
    Pasquet A; Lauer MS; Williams MJ; Secknus MA; Lytle B; Marwick TH
    Eur Heart J; 2000 Jan; 21(2):125-36. PubMed ID: 10637086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of dobutamine echocardiography for detection of myocardial viability in patients with an occluded left anterior descending coronary artery.
    Afridi I; Main ML; Grayburn PA
    J Am Coll Cardiol; 1996 Aug; 28(2):455-9. PubMed ID: 8800125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization?
    Schinkel AF; Poldermans D; Rizzello V; Vanoverschelde JL; Elhendy A; Boersma E; Roelandt JR; Bax JJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):385-90. PubMed ID: 14762345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction.
    Chaudhry FA; Tauke JT; Alessandrini RS; Vardi G; Parker MA; Bonow RO
    J Am Coll Cardiol; 1999 Sep; 34(3):730-8. PubMed ID: 10483954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography.
    Bax JJ; Poldermans D; Elhendy A; Cornel JH; Boersma E; Rambaldi R; Roelandt JR; Fioretti PM
    J Am Coll Cardiol; 1999 Jul; 34(1):163-9. PubMed ID: 10400006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of myocardial viability recognized by low-dose dobutamine echocardiography in chronic ischemic left ventricular dysfunction.
    Sicari R; Picano E; Cortigiani L; Borges AC; Varga A; Palagi C; Bigi R; Rossini R; Pasanisi E;
    Am J Cardiol; 2003 Dec; 92(11):1263-6. PubMed ID: 14636900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic implications of left ventricular cavity obliteration response to dobutamine echocardiography.
    Secknus MA; Niedermaier ON; Lauer MS; Marwick TH
    Am J Cardiol; 1998 Jun; 81(11):1318-22. PubMed ID: 9631970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of revascularisation and contractile reserve on left ventricular remodelling in patients with impaired left ventricular function.
    Khoury VK; Haluska B; Fathi R; Marwick TH
    Int J Cardiol; 2004 Jan; 93(1):55-61. PubMed ID: 14729436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of myocardial viability by delayed-enhanced magnetic resonance in patients with coronary artery disease and low ejection fraction: impact of revascularization therapy.
    Gerber BL; Rousseau MF; Ahn SA; le Polain de Waroux JB; Pouleur AC; Phlips T; Vancraeynest D; Pasquet A; Vanoverschelde JL
    J Am Coll Cardiol; 2012 Feb; 59(9):825-35. PubMed ID: 22361403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of cyclic variation of integrated backscatter to assess contractile reserve and myocardial viability in chronic ischemic left ventricular dysfunction.
    Yuda S; Dart J; Najos O; Marwick TH
    Echocardiography; 2002 May; 19(4):279-87. PubMed ID: 12047778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severity of Remodeling, Myocardial Viability, and Survival in Ischemic LV Dysfunction After Surgical Revascularization.
    Bonow RO; Castelvecchio S; Panza JA; Berman DS; Velazquez EJ; Michler RE; She L; Holly TA; Desvigne-Nickens P; Kosevic D; Rajda M; Chrzanowski L; Deja M; Lee KL; White H; Oh JK; Doenst T; Hill JA; Rouleau JL; Menicanti L;
    JACC Cardiovasc Imaging; 2015 Oct; 8(10):1121-1129. PubMed ID: 26363840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining myocardial viability in chronic ischemic left ventricular dysfunction: a prospective comparison of rest-redistribution thallium 201 single-photon emission computed tomography, nitroglycerin-dobutamine echocardiography, and intracoronary myocardial contrast echocardiography.
    Ling LH; Christian TF; Mulvagh SL; Klarich KW; Hauser MF; Nishimura RA; Pellikka PA
    Am Heart J; 2006 Apr; 151(4):882-9. PubMed ID: 16569554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial changes in response of hibernating myocardium to inotropic stimulation after revascularization: a dobutamine echocardiographic study.
    Afridi I; Qureshi U; Kopelen HA; Winters WL; Zoghbi WA
    J Am Coll Cardiol; 1997 Nov; 30(5):1233-40. PubMed ID: 9350921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.